Cytopenias secondary to copper depletion complicating ammonium tetrathiomolybdate therapy for Wilson's disease.
Karunajeewa
H
H
Wall
A
A
Metz
J
J
Grigg
A
A
D000328:Adult; D015913:Chelation Therapy / Q000009:adverse effects*; D003300:Copper; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008982:Molybdenum / Q000627:therapeutic use*; D009503:Neutropenia / Q000139:chemically induced*; D013921:Thrombocytopenia / Q000139:chemically induced*
D003300:Copper; D008982:Molybdenum; C020809:tetrathiomolybdate